Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013:2013:860201.
doi: 10.1155/2013/860201. Epub 2013 Mar 24.

Late onset atypical pantothenate-kinase-associated neurodegeneration

Affiliations

Late onset atypical pantothenate-kinase-associated neurodegeneration

Natalie Diaz. Case Rep Neurol Med. 2013.

Abstract

Introduction. Pantothenate-kinase-associated neurodegeneration (PKAN) is a rare genetic disease and a form of neurodegeneration with brain iron accumulation (NBIA). It most commonly begins in the first two decades of life but should be considered in the differential diagnosis of patients at any age with an atypical progressive extrapyramidal disorder and cognitive impairment. Few late-adult cases have been reported. Case Report. A 50-year-old woman presented with a history of progressive dysarthria and dysphagia secondary to orolingual dystonia. Initial work-up was normal. There was no family history. Her initial symptoms were followed by the onset of blepharospasm, cervical dystonia, Parkinsonism, and cognitive impairment. Follow-up MRI four years after presentation revealed the diagnostic "eye-of-the-tiger" sign. Genetic testing confirmed a homozygous missense mutation consistent with the diagnosis of PKAN. Conclusion. Although PKAN is a rare genetic disorder most commonly seen in childhood, it should be considered in adult patients with a history of progressive focal dystonia or atypical Parkinsonism. As the radiographic findings are quite characteristic, genetic testing should be performed if the MRI shows evidence of iron accumulation. Optimal treatment strategies are not known, and at the current time therapies should be directed at the specific manifestations of the disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a) Axial T1 weighted, (b) coronal T2 weighted, and (c) axial fluid attenuation inversion recovery MRI showing low signal intensity in the bilateral globus pallidus with a medial area of signal intensity, presenting the classic “eye-of-the-tiger” sign. (d) Axial fluid attenuation inversion recovery MRI shows bilateral low signal intensity in the substantia nigra pars reticulata.

References

    1. Hallervorden J, Spatz H. Eigenartige erkrankung im extrapyramidalen system mit besonderer beteiligung des globus pallidus und der substantia nigra. Zeitschrift für die gesamte Neurologie und Psychiatrie. 1922;79(1):254–302.
    1. Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, Hayflick SJ. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nature Genetics. 2001;28(4):345–349. - PubMed
    1. Hayflick SJ, Westaway SK, Levinson B, et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. New England Journal of Medicine. 2003;348(1):33–40. - PubMed
    1. Oner O, Oner P, Deda G, et al. Psychotic disorder in a case with Hallervorder-Spatz disease. Acta Psychiatrica Scandinavica. 2003;108(5):394–397. - PubMed
    1. del Valle-López P, Pérez-García R, Sanguino-Andrés R, González-Pablos E. Adult onset Hallervorden-Spatz disease with psychotic symptoms. Actas Españolas de Psiquiatría. 2011;39(4):260–262. - PubMed

LinkOut - more resources